Understanding the Different Phases of Clinical Trials
- temidayodada
- Nov 4, 2025
- 3 min read
After learning what the MHRA does and how Regulatory Affairs fits into the picture, I realised there was still a gap in my understanding: clinical trials
I knew there were different phases – Phase 1, Phase 2, Phase 3 (and sometimes Phase 4) – but if someone asked me what actually happens in each phase, I wouldn’t have been able to explain it clearly.
So I decided to sit down and understand clinical trials properly – not as definitions to memorise, but as a logical process. This is the explanation that finally made it click for me.
What Are Clinical Trials?
At the most basic level, clinical trials exist to answer one core question: Is this medicine safe and effective enough to be used in real patients?
They don’t jump straight to large populations or big claims. Instead, evidence is built step by step, increasing scale and risk gradually. Each phase has a specific purpose.
Phase 1: "Is this safe in humans"
Phase 1 is the first time a new treatment is tested in humans. This phase usually involves a small group of 20 to 100 healthy volunteers or sometimes patients. The main goal is to assess safety and find the right dose.
What Happens in Phase 1?
Researchers give participants the treatment in increasing doses.
They monitor side effects and how the body processes the treatment.
The focus is on safety, not effectiveness.
Why Phase 1 Matters
This phase helps identify any immediate risks and determines the safest dose to use in later phases. For example, a new cancer drug might be tested in Phase 1 to see how the body absorbs it and what side effects occur.
Phase 2: "Does it work, and what dose is best?"
Once Phase 1 shows the treatment is safe, Phase 2 tests it on a larger group of 100 to 300 patients who have the condition the treatment targets. This phase focuses on whether the treatment works and continues to monitor safety. This is often where drugs fail – not because they’re unsafe, but because they don’t work well enough.
What Happens in Phase 2?
Participants receive the treatment at the dose found safe in Phase 1.
Researchers measure how well the treatment works.
Side effects are recorded and analysed.
Example of Phase 2
A new medication for diabetes might be given to patients to see if it lowers blood sugar levels effectively. Researchers also watch for any adverse reactions.
Phase 3: “Does this work at scale?”
Phase 3 involves a much larger group, often 1,000 to 3,000 patients. This phase compares the new treatment to the current standard treatment or a placebo. It aims to confirm effectiveness, monitor side effects, and collect information that will allow the treatment to be used safely.
What Happens in Phase 3?
Participants are randomly assigned to receive either the new treatment or a control (standard treatment or placebo).
Researchers track outcomes over a longer period.
Data collected supports regulatory approval.
Importance of Phase 3
This phase provides the strongest evidence about the treatment’s benefits and risks. For example, a vaccine might go through Phase 3 to prove it prevents disease better than no vaccine or an existing one.
Phase 4: “What happens in the real world?”
After a treatment receives approval and becomes available to the public, Phase 4 studies continue to monitor its safety and effectiveness in the general population. This phase can last for years.
What Happens in Phase 4?
Researchers collect data on long-term effects.
They identify rare side effects not seen in earlier phases.
The treatment’s use in different populations is studied.
Why Phase 4 Is Crucial
Some side effects only appear when thousands or millions of people use a treatment. For example, a medication might be linked to rare allergic reactions after widespread use, which Phase 4 studies help detect.
What surprised me while learning this
Most drugs never make it past Phase 2
Approval is based on accumulated evidence, not a single study
Safety monitoring continues long after launch
Clinical trials are as much about risk management as effectiveness
It’s a much more cautious and structured system than I initially assumed.
Final thoughts
Clinical trial phases aren’t just labels – they’re a carefully designed process to reduce uncertainty and protect patients. Writing this helped me move from recognising the terms to actually understanding the logic behind them.
That’s exactly what I want this blog to do.
